Health News

The rates of men dying from malignant melanoma - the deadliest form of skin cancer - have doubled in the last 30 years, according to the latest Cancer Research UK figures published last friday. In the late 70s fewer than 400 (1.5 per 100,000) men died from melanoma but now more than 1100 (3.1 per 100,000) men are dying from the disease1…

Read more

Filed under: Men's Health
Tags: cancer, Men's Health, skin cancer

Related posts

• Wayne State University Scientists ID New Biomarker For Prostate Cancer (0)
  Researchers at Wayne State University have identified a new marker for prostate cancer progression that may one day lead to new treatments. Prostate cancer, one of the most prevalent non-skin cancers in America, affects one in six men. In 2008, nearly two million Americans were being treated for prostate cancer; nearly 186,000 [...]
  
  
• Lower Antioxidant Level Might Explain Higher Skin-Cancer Rate In Males (0)
  Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read more [tags] Men's Health [/tags]
  
  
• Gender Disparity In Skin-Cancer Rate May Be Explained By Antioxidant Levels (0)
  Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read more [tags] Men's Health [/tags]
  
  
• ZERO Outraged Docs Don’t Offer Solution In PSA Crisis (0)
  A new study of the effectiveness of the PSA test for prostate cancer is yet another claim prostate cancer screening has little to no value in lowering the death rate with offering no solutions to the problem. Read more [tags] Men's Health [/tags]
  
  
• Zelboraf receives FDA approval for treatment of metastatic melanoma (0)
  The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer. Read more [tags] Pharmacy News [/tags]